Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy
Authors:
- Amy M. WinansAWAmy M. Winans
- Catherine C. HuangCHCatherine C. Huang
- Elizabeth M. HorriganEHElizabeth M. Horrigan
- Darrell J. IrvineDIDarrell J. Irvine
- 1 September 2008
- journal article
- Published by Elsevier in Biomaterials
- Vol. 29 (27) , 3671-3682
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Lymphoid tissue engineering: Invoking lymphoid tissue neogenesis in immunotherapy and models of immunitySeminars in Immunology, 2008
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- DC-based cancer vaccinesJournal of Clinical Investigation, 2007
- Regulatory T cells and cancerCurrent Opinion in Immunology, 2007
- The biological relevance of chemokine–proteoglycan interactionsBiochemical Society Transactions, 2006
- Dendritic-cell-based therapeutic vaccination against cancerCurrent Opinion in Immunology, 2005
- Intrinsic Lymphotoxin-β Receptor Requirement for Homeostasis of Lymphoid Tissue Dendritic CellsImmunity, 2005
- Aggregation of Antigen-Specific T Cells at the Inoculation Site of Mature Dendritic CellsJournal of Investigative Dermatology, 2002
- Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice.Journal of Clinical Investigation, 1996
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.Journal of Experimental Medicine, 1992